|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
Insider Trading - XERIS PHARMACEUTICALS INC (XERS)
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch What is insider trading>> |
Historical filings delayed by 6 months. New user? Sign Up for real time data. Existing user? Sign In
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2019-02-19 Purchase |
2019-02-25 5:38 pm |
XERIS PHARMACEUTICALS INC | XERS | JOHNSON KENNETH ERLAND See Remarks |
1,000 | $10 | $10,000 | 3,245 (Direct) |
View |
| 2019-02-19 Purchase |
2019-02-22 8:18 pm |
XERIS PHARMACEUTICALS INC | XERS | Deutsch Barry M. See Remarks |
5,000 | $10 | $50,000 | 28,292 (Direct) |
View |
| 2019-02-19 Purchase |
2019-02-22 4:36 pm |
XERIS PHARMACEUTICALS INC | XERS | Hecht Beth See Remarks |
2,500 | $10 | $25,000 | 2,500 (Direct) |
View |
| 2019-02-19 Purchase |
2019-02-21 4:18 pm |
XERIS PHARMACEUTICALS INC | XERS | Redmile Group LLC Green Jeremy 10% Owner |
588,000 | $10 | $5,880,000 | 3,000,642 (Indirect) |
View |
| 2019-02-08 Sale |
2019-02-12 5:55 pm |
XERIS PHARMACEUTICALS INC | XERS | Flynn James E Deerfield Mgmt L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Special Situations Fund L.P. Deerfield Mgmt III L.P. Deerfield Private Design Fund III L.P. 10% Owner |
7,241 | $15.09 | $109,251 | 1,498,666 (Indirect) |
View |
| 2019-02-05 Sale |
2019-02-07 8:13 pm |
XERIS PHARMACEUTICALS INC | XERS | Flynn James E Deerfield Mgmt L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Special Situations Fund L.P. Deerfield Mgmt III L.P. Deerfield Private Design Fund III L.P. 10% Owner |
14,807 | $15.02 | $222,443 | 1,498,666 (Indirect) |
View |
| 2019-01-28 Sale |
2019-01-30 5:38 pm |
XERIS PHARMACEUTICALS INC | XERS | Flynn James E Deerfield Mgmt L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Special Situations Fund L.P. Deerfield Mgmt III L.P. Deerfield Private Design Fund III L.P. 10% Owner |
7,038 | $15.12 | $106,448 | 1,498,666 (Indirect) |
View |
| 2019-01-23 Sale |
2019-01-25 6:24 pm |
XERIS PHARMACEUTICALS INC | XERS | Flynn James E Deerfield Mgmt L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Special Situations Fund L.P. Deerfield Mgmt III L.P. Deerfield Private Design Fund III L.P. 10% Owner |
114,444 | $15.43 | $1,766,193 | 1,498,666 (Indirect) |
View |
| 2019-01-11 Sale |
2019-01-15 4:11 pm |
XERIS PHARMACEUTICALS INC | XERS | PRESTRELSKI STEVEN Chief Scientific Officer |
2,300 | $0 | $0 | 487,024 (Direct) |
View |
| 2018-12-24 Sale |
2019-01-02 6:25 pm |
XERIS PHARMACEUTICALS INC | XERS | PRESTRELSKI STEVEN Chief Scientific Officer |
15,720 | $15.82 | $248,738 | 505,044 (Direct) |
View |
| 2018-06-25 Purchase |
2018-06-27 4:58 pm |
XERIS PHARMACEUTICALS INC | XERS | Flynn James E Deerfield Mgmt L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Special Situations Fund L.P. Deerfield Mgmt III L.P. Deerfield Private Design Fund III L.P. 10% Owner |
750,000 | $15 | $11,250,000 | 1,498,666 (Indirect) |
View |
| 2018-06-25 Purchase |
2018-06-27 4:15 pm |
XERIS PHARMACEUTICALS INC | XERS | Redmile Group LLC Green Jeremy 10% Owner |
666,668 | $15 | $10,000,020 | 2,412,642 (Indirect) |
View |
| 2018-06-25 Purchase |
2018-06-25 7:16 pm |
XERIS PHARMACEUTICALS INC | XERS | Palmetto Partners Ltd. Palmetto Partners 2014 LP Palmetto Partners 2015 LP 10% Owner |
150,000 | $15 | $2,250,000 | 2,110,061 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2019-01-31 Option Award |
2019-02-01 4:44 pm |
N/A 2029-01-31 |
XERIS PHARMACEUTICALS INC | XERS | Deutsch Barry M. See Remarks |
25,000 | $13.88 | 25,000 (Direct) |
View |
| 2019-01-31 Option Award |
2019-02-01 4:43 pm |
N/A 2029-01-31 |
XERIS PHARMACEUTICALS INC | XERS | PRESTRELSKI STEVEN See Remarks |
25,000 | $13.88 | 25,000 (Direct) |
View |
| 2019-01-31 Option Award |
2019-02-01 4:42 pm |
N/A N/A |
XERIS PHARMACEUTICALS INC | XERS | Edick Paul R Director |
125,000 | $0 | 200,000 (Direct) |
View |
| 2019-01-31 Option Award |
2019-02-01 4:42 pm |
N/A 2029-01-31 |
XERIS PHARMACEUTICALS INC | XERS | Edick Paul R Director |
200,000 | $13.88 | 200,000 (Direct) |
View |
| 2019-01-31 Option Award |
2019-02-01 4:40 pm |
N/A 2029-01-31 |
XERIS PHARMACEUTICALS INC | XERS | JOHNSON KENNETH ERLAND See Remarks |
32,500 | $13.88 | 32,500 (Direct) |
View |
| 2019-01-31 Option Award |
2019-02-01 4:38 pm |
N/A 2029-01-31 |
XERIS PHARMACEUTICALS INC | XERS | Shannon John Patrick Jr See Remarks |
80,000 | $13.88 | 80,000 (Direct) |
View |
| 2019-01-31 Option Award |
2019-02-01 4:38 pm |
N/A 2029-01-31 |
XERIS PHARMACEUTICALS INC | XERS | Hecht Beth See Remarks |
32,500 | $13.88 | 32,500 (Direct) |
View |
| 2018-12-24 Exercise |
2019-01-02 6:25 pm |
N/A N/A |
XERIS PHARMACEUTICALS INC | XERS | PRESTRELSKI STEVEN Chief Scientific Officer |
15,720 | $1.19 | 505,044 (Direct) |
View |
| 2018-12-24 Exercise |
2019-01-02 6:25 pm |
N/A 2023-12-26 |
XERIS PHARMACEUTICALS INC | XERS | PRESTRELSKI STEVEN Chief Scientific Officer |
15,720 | $1.19 | 505,044 (Direct) |
View |
| 2018-06-25 Conversion |
2018-06-28 08:47 am |
N/A N/A |
XERIS PHARMACEUTICALS INC | XERS | Palmetto Partners Ltd. Palmetto Partners 2014 LP Palmetto Partners 2015 LP 10% Owner |
1,657,125 | $0 | 0 (Direct) |
View |
| 2018-06-25 Conversion |
2018-06-28 08:47 am |
N/A N/A |
XERIS PHARMACEUTICALS INC | XERS | Palmetto Partners Ltd. Palmetto Partners 2014 LP Palmetto Partners 2015 LP 10% Owner |
1,036,599 | $0 | 0 (Direct) |
View |
| 2018-06-25 Conversion |
2018-06-28 08:47 am |
N/A N/A |
XERIS PHARMACEUTICALS INC | XERS | Palmetto Partners Ltd. Palmetto Partners 2014 LP Palmetto Partners 2015 LP 10% Owner |
797,384 | $0 | 0 (Direct) |
View |
| 2018-06-25 Conversion |
2018-06-27 8:38 pm |
N/A N/A |
XERIS PHARMACEUTICALS INC | XERS | Edick Paul R Director |
13,430 | $0 | 13,430 (Indirect) |
View |
| 2018-06-25 Conversion |
2018-06-27 8:38 pm |
N/A N/A |
XERIS PHARMACEUTICALS INC | XERS | Edick Paul R Director |
23,922 | $0 | 13,430 (Indirect) |
View |
| 2018-06-25 Conversion |
2018-06-27 8:38 pm |
N/A N/A |
XERIS PHARMACEUTICALS INC | XERS | Deutsch Barry M. CFO |
2,238 | $0 | 23,292 (Direct) |
View |
| 2018-06-25 Conversion |
2018-06-27 8:38 pm |
N/A N/A |
XERIS PHARMACEUTICALS INC | XERS | Deutsch Barry M. CFO |
3,987 | $0 | 23,292 (Direct) |
View |
| 2018-06-25 Conversion |
2018-06-27 8:35 pm |
N/A N/A |
XERIS PHARMACEUTICALS INC | XERS | Shannon John Patrick Jr See Remarks |
8,983 | $0 | 8,983 (Direct) |
View |
| 2018-06-25 Conversion |
2018-06-27 8:35 pm |
N/A N/A |
XERIS PHARMACEUTICALS INC | XERS | Shannon John Patrick Jr See Remarks |
16,000 | $0 | 8,983 (Direct) |
View |
| 2018-06-25 Conversion |
2018-06-27 8:35 pm |
N/A N/A |
XERIS PHARMACEUTICALS INC | XERS | PRESTRELSKI STEVEN Chief Scientific Officer |
30,232 | $0 | 489,323 (Direct) |
View |
| 2018-06-25 Conversion |
2018-06-27 8:35 pm |
N/A N/A |
XERIS PHARMACEUTICALS INC | XERS | PRESTRELSKI STEVEN Chief Scientific Officer |
7,130 | $0 | 489,323 (Direct) |
View |
| 2018-06-25 Conversion |
2018-06-27 8:35 pm |
N/A N/A |
XERIS PHARMACEUTICALS INC | XERS | PRESTRELSKI STEVEN Chief Scientific Officer |
53,849 | $0 | 489,323 (Direct) |
View |
| 2018-06-25 Conversion |
2018-06-27 8:35 pm |
N/A N/A |
XERIS PHARMACEUTICALS INC | XERS | PRESTRELSKI STEVEN Chief Scientific Officer |
12,701 | $0 | 489,323 (Direct) |
View |
| 2018-06-25 Conversion |
2018-06-27 8:35 pm |
N/A N/A |
XERIS PHARMACEUTICALS INC | XERS | JOHNSON KENNETH ERLAND See Remarks |
2,245 | $0 | 2,245 (Direct) |
View |
| 2018-06-25 Conversion |
2018-06-27 8:35 pm |
N/A N/A |
XERIS PHARMACEUTICALS INC | XERS | JOHNSON KENNETH ERLAND See Remarks |
4,000 | $0 | 2,245 (Direct) |
View |
| 2018-06-25 Conversion |
2018-06-27 4:58 pm |
N/A N/A |
XERIS PHARMACEUTICALS INC | XERS | Flynn James E Deerfield Mgmt L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Special Situations Fund L.P. Deerfield Mgmt III L.P. Deerfield Private Design Fund III L.P. 10% Owner |
874,333 | $0 | 1,498,666 (Indirect) |
View |
| 2018-06-25 Conversion |
2018-06-27 4:58 pm |
N/A N/A |
XERIS PHARMACEUTICALS INC | XERS | Flynn James E Deerfield Mgmt L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Special Situations Fund L.P. Deerfield Mgmt III L.P. Deerfield Private Design Fund III L.P. 10% Owner |
874,333 | $0 | 1,498,666 (Indirect) |
View |
| 2018-06-25 Conversion |
2018-06-27 4:58 pm |
N/A N/A |
XERIS PHARMACEUTICALS INC | XERS | Flynn James E Deerfield Mgmt L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Special Situations Fund L.P. Deerfield Mgmt III L.P. Deerfield Private Design Fund III L.P. 10% Owner |
1,557,292 | $0 | 1,498,666 (Indirect) |
View |
| 2018-06-25 Conversion |
2018-06-27 4:58 pm |
N/A N/A |
XERIS PHARMACEUTICALS INC | XERS | Flynn James E Deerfield Mgmt L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Special Situations Fund L.P. Deerfield Mgmt III L.P. Deerfield Private Design Fund III L.P. 10% Owner |
1,557,292 | $0 | 1,498,666 (Indirect) |
View |
| 2018-06-25 Conversion |
2018-06-27 4:15 pm |
N/A N/A |
XERIS PHARMACEUTICALS INC | XERS | Redmile Group LLC Green Jeremy 10% Owner |
1,745,974 | $0 | 2,412,642 (Indirect) |
View |
| 2018-06-25 Conversion |
2018-06-27 4:15 pm |
N/A N/A |
XERIS PHARMACEUTICALS INC | XERS | Redmile Group LLC Green Jeremy 10% Owner |
3,109,796 | $0 | 2,412,642 (Indirect) |
View |
| 2018-06-25 Conversion |
2018-06-25 7:16 pm |
N/A N/A |
XERIS PHARMACEUTICALS INC | XERS | Palmetto Partners Ltd. Palmetto Partners 2014 LP Palmetto Partners 2015 LP 10% Owner |
930,383 | $0 | 2,110,061 (Direct) |
View |
| 2018-06-25 Conversion |
2018-06-25 7:16 pm |
N/A N/A |
XERIS PHARMACEUTICALS INC | XERS | Palmetto Partners Ltd. Palmetto Partners 2014 LP Palmetto Partners 2015 LP 10% Owner |
581,992 | $0 | 2,110,061 (Direct) |
View |
| 2018-06-25 Conversion |
2018-06-25 7:16 pm |
N/A N/A |
XERIS PHARMACEUTICALS INC | XERS | Palmetto Partners Ltd. Palmetto Partners 2014 LP Palmetto Partners 2015 LP 10% Owner |
447,686 | $0 | 2,110,061 (Direct) |
View |
| 2018-06-25 Conversion |
2018-06-25 7:16 pm |
N/A N/A |
XERIS PHARMACEUTICALS INC | XERS | Palmetto Partners Ltd. Palmetto Partners 2014 LP Palmetto Partners 2015 LP 10% Owner |
1,657,125 | $0 | 2,110,061 (Direct) |
View |
| 2018-06-25 Conversion |
2018-06-25 7:16 pm |
N/A N/A |
XERIS PHARMACEUTICALS INC | XERS | Palmetto Partners Ltd. Palmetto Partners 2014 LP Palmetto Partners 2015 LP 10% Owner |
1,036,599 | $0 | 2,110,061 (Direct) |
View |
| 2018-06-25 Conversion |
2018-06-25 7:16 pm |
N/A N/A |
XERIS PHARMACEUTICALS INC | XERS | Palmetto Partners Ltd. Palmetto Partners 2014 LP Palmetto Partners 2015 LP 10% Owner |
797,384 | $0 | 2,110,061 (Direct) |
View |
|
© 2005-2019 SecForm4.Com All rights reserved. Archives: 2019 2018 2017 2016 2015 2014 ... Sat, 24 Aug 2019 12:59:37 -0500 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |